// App-Quantinova.ai

Sa1164 : Treatment of Crohn's Disease With Anti-Tumor Necrosis Factor Decreases Levels of C-Reactive Protein: a Systematic Review and Meta-Analysis

Researchers

Presenter

  • Isabelle A. Vallerand

Principal Investigators

  • Remo Panaccione

  • Cynthia H. Seow

  • Yvette Leung

  • Steven J. Heitman

  • Subrata Ghosh

  • Gilaad G. Kaplan

Medical Centers

  • Dept of Community Health Sciences, Univ of Calgary, Calgary, Canada

  • Division of Nephrology, University of Calgary, Calgary, AB, Canada

Locations

  • Canada

Companies

  • N/A

Study Components

Therapeutic Area

  • Musculoskeletal

  • Genetic Disorder

Disease

  • Crohn's disease

  • Spondylometaphyseal dysplasia, sedaghatian type

Biomarkers

  • Nucleoside diphosphate kinase A

  • C reactive protein

Drug/Treatment

  • Certolizumab pegol

  • Adalimumab

  • Infliximab

Outcome

  • N/A

Study Design

  • randomized

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • Interim

Copyright © 2026. QuantiNova All rights reserved